过敏性哮喘患者抗IgE治疗智慧提醒系统的设计及应用

doi:10.3761/j.issn.0254-1769.2021.07.005

摘要/Abstract

摘要：

目的设计、开发过敏性哮喘患者抗IgE治疗智慧提醒系统并评价其应用效果。方法基于专家共识、药品说明书和临床实践经验,设计开发具有注射提醒、预约提醒、适应证错误提醒和健康教育内容提醒功能的抗IgE治疗智慧提醒系统。便利选取2019年5月—10月在湖北省某三级甲等医院门诊接受抗IgE治疗的22例过敏性哮喘患者作为试验组,应用智慧提醒系统实施干预;选取2018年11月—2019年4月接受抗IgE治疗的19例过敏性哮喘患者作为对照组,采用常规护理措施。于患者接受治疗后第12周,比较两组护理缺陷率、患者满意度、治疗依从性。结果试验组在患者评估、药物配置、观察及处理不良反应和健康教育等环节的护理缺陷率均低于对照组,差异具有统计学意义（P<0.05）;用药准备和注射环节护理缺陷率比较,差异无统计学意义（P>0.05）。试验组对护理工作流程、工作效率、注射技术、隐私保护、健康教育和整体感受等方面的满意度均高于对照组,差异具有统计学意义（P<0.05）;态度与沟通方面满意度比较,差异无统计学意义（P>0.05）。试验组治疗依从率和治疗依从性良好率高于对照组,差异具有统计学意义（P<0.05）。结论应用智慧提醒系统可规范抗IgE治疗中的护理行为,减少护理缺陷,提高患者满意度及治疗依从性。

关键词: 信息系统, 哮喘, 抗IgE治疗, 护理

Abstract:

Objective To design and develop an intelligent reminder system in allergic asthma patients with anti-IgE therapy and to evaluate its effects. Methods Based on expert consensuses,medicine instructions and clinical experience,an intelligent reminder system was developed,with the function of injection and appointment reminding,indications errors warning and patient education reminding. All participants were recruited from a tertiary hospital clinic in Hubei province by convenient sampling. The intervention group of 22 allergic asthma patients was prescribed with the anti-IgE therapy and was provided with the intelligent reminder system intervention from May to October 2019. While 19 cases,from November 2018 to April 2019,as the control group were also treated with anti-IgE therapy but received routine nursing care. The incidence of nursing defects,patient satisfaction and treatment compliance were compared between the 2 groups at the 12th week after the first injection. Results With the application of the intelligent reminder system,the incidences of nursing defects in patient evaluation,drug admixture,observation and management of adverse reactions,and health education were dramatically decreased（P<0.05）,while the differences of incidences of nursing defects in preparation and injection were not shown between the 2 groups（P>0.05）. Patients in the intervention group were more satisfied with working procedure,work efficiency,injection technology,privacy protection,health education and overall feelings than those in the control group（P<0.05）,but the difference of attitude and communication was not observed in the 2 groups（P>0.05）. The treatment compliance rate and the good compliance rate in the intervention group were much higher than those in the control group（P<0.05）. Conclusion The application of the intelligent reminder system in anti-IgE therapy could standardize nursing behaviors,reduce nursing defects,improve patient satisfaction and increase treatment compliance.

Key words: Information Systems, Asthma, Anti-IgE Therapy, Nursing Care

于文蓁,王思,赵东,胡克. 过敏性哮喘患者抗IgE治疗智慧提醒系统的设计及应用[J]. 中华护理杂志, 2021, 56(7): 991-996.

YU Wenzhen,WANG Si,ZHAO Dong,HU Ke. Design and application of an intelligent reminder system in allergic asthma patients with anti-IgE therapy[J]. Chinese Journal of Nursing, 2021, 56(7): 991-996.

图/表 3

表1 两组的一般资料比较[例（百分比,%）]

Table 1 Baseline characteristics of participants in the intervention and control groups[cases（percentage,%）]

表2 两组护理缺陷率比较[例（百分率,%）]

Table 2 Differences between two groups in incidence of nursing defects [cases（percentage,%）]

表3 两组患者满意度比较[分,M（P25,P75）]

Table 3 Differences between two groups in patient satisfaction[scores,M（P25,P75）]

参考文献 13

[1]	Huang KW, Yang T, Xu JY, et al. Prevalence,risk factors,and management of asthma in China:a national cross-sectional study[J]. Lancet, 2019, 394(10196):407-418. DOI PMID
[2]	中华医学会变态反应分会呼吸过敏学组（筹）, 中华医学会呼吸病学分会哮喘学组. 中国过敏性哮喘诊治指南(第一版,2019年)[J]. 中华内科杂志, 2019, 58(9):636-655.
	The Respiratory Allergy Group of Chinese Society of Allergy, The Asthma Group of Chinese Thoracic Society,Chinese Medical Association. Chinese guidelines for the diagnosis and treatment of allergic asthma(2019,1st ed)[J]. Chin J Intern Med, 2019, 58(9):636-655.
[3]	林江涛, 王文巧, 周新, 等. 我国30个省市城区门诊支气管哮喘患者控制水平的调查结果[J]. 中华结核和呼吸杂志, 2017, 40(7):494-498.
	Lin JT, Wang WQ, Zhou X, et al. The level of asthma control in China from a national asthma control survey[J]. Chin J Tuberc Respir Dis, 2017, 40(7):494-498.
[4]	奥马珠单抗治疗过敏性哮喘专家组, 中华医学会呼吸病学分会哮喘学组. 奥马珠单抗治疗过敏性哮喘的中国专家共识[J]. 中华结核和呼吸杂志, 2018, 41(3):179-185.
	The Expert Group of Omalizumab Treatment of Allergic Asthma, The Asthma Group of Chinese Thoracic Society, Chinese Medical Association. Chinese expert consensus on omalizumab in the treatment of allergic asthma[J]. Chin J Tuberc Respir Dis, 2018, 41(3):179-185.
[5]	蔡慧, 墨玉清, 薛小敏, 等. 真实世界奥马珠单抗治疗中重度过敏性哮喘的疗效及安全性[J]. 中华临床免疫和变态反应杂志, 2019, 13(3):199-204.
	Cai H, Mo YQ, Xue XM, et al. Real-world study on efficacy and safety of omalizumab for treatment of moderate-to-severe asthma[J]. Chin J Allergy Clin Immunol, 2019, 13(3):199-204.
[6]	朱力, 史冬雷, 王军, 等. 信息化采血登记平台的构建及应用[J]. 中华护理杂志, 2020, 55(3):383-386.
	Zhu L, Shi DL, Wang J, et al. Construction and application of an informationized platform of blood collection[J]. Chin J Nurs, 2020, 55(3):383-386.
[7]	孙玉娇, 史婷奇, 张宁, 等. 低血糖护理决策支持系统的设计及应用[J]. 中华护理杂志, 2020, 55(7):1028-1032.
	Sun YJ, Shi TQ, Zhang N, et al. Design and application of hypoglycemia nursing decision support system[J]. Chin J Nurs, 2020, 55(7):1028-1032.
[8]	中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志, 2016, 39(9):675-697.
	The Asthma Group of Chinese Thoracic Society,Chinese Medical Association. Chinese guidelines for the prevention and treatment of asthma(2016 ed)[J]. Chin J Tuberc Respir Dis, 2016, 39(9):675-697.
[9]	支凡, 王青, 杨永仕, 等. 奥马珠单抗注射治疗138例过敏性疾病患者的流程管理及安全性[J]. 中华临床免疫和变态反应杂志, 2020, 14(3):221-227.
	Zhi F, Wang Q, Yang YS, et al. Retrospective study on process management and safety evaluation of omalizumab therapy among 138 patients[J]. Chin J Allergy Clin Immunol, 2020, 14(3):221-227.
[10]	赵永信, 顾莺, 张晓波, 等. 住院患儿疼痛管理决策支持系统的构建与应用研究[J]. 中华护理杂志, 2020, 55(8):1147-1153.
	Zhao YX, Gu Y, Zhang XB, et al. Construction and application of the decision support system for pain management in hospitalized children[J]. Chin J Nurs, 2020, 55(8):1147-1153.
[11]	王红燕, 冯素文, 谢臻蔚, 等. 孕产妇盆底功能康复信息化管理平台的构建及应用[J]. 中华护理杂志, 2018, 53(7):801-805.
	Wang HY, Feng SW, Xie ZW, et al. Construction and application of an information platform for rehabilitation of maternal pelvic floor function[J]. Chin J Nurs, 2018, 53(7):801-805.
[12]	Campisi R, Crimi C, Intravaia R, et al. Adherence to omalizumab:a multicenter “real-world” study[J]. World Allergy Organ J, 2020, 13(2):100103. DOI URL
[13]	施宇衡, 汤葳, 段玉香, 等. 上海地区成人哮喘患者治疗依从性的影响因素分析[J]. 国际呼吸杂志, 2019, 39(7):481-486.
	Shi YH, Tang W, Duan YX, et al. Influence factors of treatment compliance in adult asthma patients in Shanghai[J]. Int J Respir, 2019, 39(7):481-486.

[1]	韩冬芳, 田甜, 高畅, 张婧珺, 李小妹. 肺结核患者健康促进行为与健康心理控制源关系的混合研究[J]. 中华护理杂志, 2024, 59(9): 1029-1036.
[2]	司茜茜, 王莹, 赵福云, 马晓骁, 刘均娥. A型主动脉夹层患者Ⅰ期心肺康复护理方案的构建及应用[J]. 中华护理杂志, 2024, 59(9): 1037-1042.
[3]	沈支佳, 陈新宇, 钱志杰, 殷丽梅. 反复低血糖患者血糖管理行为退化特征的混合研究[J]. 中华护理杂志, 2024, 59(9): 1043-1050.
[4]	王丽梅, 李露, 李玉霞, 喻鹏, 罗倩, 张翀旎. 糖尿病周围神经病理性疼痛患者运动恐惧现状及影响因素分析[J]. 中华护理杂志, 2024, 59(9): 1051-1056.
[5]	丁慧敏, 戴莉敏, 蔡冬青, 杨群. 糖尿病前期患者自我管理潜在剖面分析及影响因素研究[J]. 中华护理杂志, 2024, 59(9): 1057-1064.
[6]	刘海婷, 王咏梅, 郑贝贝, 蔡丽丽, 叶林斌, 吴佳芸, 宁丽, 李益民, 陈为霞. 冠心病合并糖尿病患者药物素养自评量表的编制及信效度检验[J]. 中华护理杂志, 2024, 59(9): 1065-1071.
[7]	陈丽霞, 施慧, 朱德政, 曾莹. 成人低血糖恐惧评估工具的质量评价[J]. 中华护理杂志, 2024, 59(9): 1072-1079.
[8]	中国研究型医院学会过敏医学专业委员会, 中华医学会变态反应分会过敏性疾病护理学组（筹）, 中华预防医学会过敏病预防与控制专业委员会, （执笔：王青刘君支凡万文锦田丰英霍晓鹏周文华杨永仕王田田孙劲旅）. 变应原特异性免疫治疗皮下注射护理的专家共识[J]. 中华护理杂志, 2024, 59(9): 1080-1083.
[9]	李琪, 苏晴晴, 张瑶瑶, 王田田, 吕静, 李亚可, 李海燕. 全膝关节置换患者关节遗忘变化轨迹及影响因素研究[J]. 中华护理杂志, 2024, 59(9): 1084-1090.
[10]	刘娅, 刘晓晴, 杨雪凝, 王平, 刘学奎, 罗丹. 结肠镜检查患者肠道准备失败风险预测模型的构建及验证[J]. 中华护理杂志, 2024, 59(9): 1091-1098.
[11]	孙晓晴, 张爱霞, 朱珠, 樊雪梅, 梅士娟, 黄欣欣, 丛胜楠, 谢红燕. 分娩心理创伤评估量表的编制及信效度检验[J]. 中华护理杂志, 2024, 59(9): 1099-1105.
[12]	谢玉生, 黄蓉蓉, 赵雪, 马蕾, 胡雁, 杨倩, 王乾沙, 明玥. 成人重度烧伤患者肠内肠外营养的证据总结[J]. 中华护理杂志, 2024, 59(9): 1106-1113.
[13]	李旭琴, 冯洁惠, 黄昉芳, 俞超, 梁诗雨, 王晓, 李旭芳, 朱含. 1例行机械循环辅助桥接心脏移植患者的术前护理[J]. 中华护理杂志, 2024, 59(9): 1114-1117.
[14]	贾晓静, 陈一竹, 许志英, 和霞, 耿超. 1例尿黑酸尿症双膝关节置换术后患者并发急性心肌梗死的护理[J]. 中华护理杂志, 2024, 59(9): 1118-1121.
[15]	顾培培, 曾妃, 兰美娟, 梁江淑渊, 郭璐瑶, 蔡凌云, 朱岩, 郭鸽. 肺移植患者衰弱影响因素的Meta分析[J]. 中华护理杂志, 2024, 59(9): 1122-1129.